Picture of Ergomed logo

ERGO — Ergomed Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Momentum

Relative Strength (%)
1m-4.01%
3m-20.21%
6m-29.75%
1yr-24.19%
Volume Change (%)
10d/3m+18.44%
Price vs... (%)
52w High-39.75%
50d MA-15.4%
200d MA-25.03%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)21.62
PEG Ratio (f)1.48
EPS Growth (f)17.14%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value7.03
Price to Tang. Book13.25
Price to Free Cashflow26.72
Price to Sales3.99
EV to EBITDA22.59

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital20.71%
Return on Equity21.1%
Operating Margin12.33%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m47.6254.1168.2586.39118.58137.97159.0624.76%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a+39.52+66.36+22.52+12.21n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for ERGO

Will the Ergomed (LON:ERGO) share price keep rising? background image

Will the Ergomed (LON:ERGO) share price keep rising?

Despite general economic uncertainty, shares in Ergomed (LON:ERGO) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue. Finding stocks with the potential to break-out as...

Will Ergomed's price keep rising? background image

Will Ergomed's price keep rising?

Studies by leading experts into the power of price momentum show that stocks with the strongest price trends can potentially keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology...

What is the broker consensus view on Ergomed? background image

What is the broker consensus view on Ergomed?

'Buy' and 'sell' recommendations from company analysts often catch the attention of investors - but it's worth remembering that city experts can get things wrong. So rather than relying on just one recommendation, a potentially better...

Which way is the Ergomed share price trending? background image

Which way is the Ergomed share price trending?

Despite economic uncertainty and market volatility, shares in Ergomed (LON:ERGO) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue. Finding stocks with the potential t...

Ergomed (LON:ERGO) price about to hit new 52-week high background image

Ergomed (LON:ERGO) price about to hit new 52-week high

The good news for any holders of Ergomed (LON:ERGO) is that the price is currently trading close to a 52 week high, with the share price up by around 26.5% to 1304.4625 over the past week.  For investors holding the stock (or consideri...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Ergomed EPS forecast chart

Profile Summary

Ergomed plc is primarily focused on providing services to the biopharmaceutical industry. The Company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). CRO segment is the process of developing medical therapies, drugs and knowledge for safe use in healthcare. PV segment is engaged in the activities relating to the detection, understanding and prevention of adverse effects or other drug-related problems throughout its lifecycle. The Company operates approximately 24 offices around the world, providing its services in over 100 countries globally. It operates in North America, United Kingdom and Europe, Middle East and Africa, and Asia. The Company’s subsidiaries include Ergomed GmbH, Ergomed Sp. z o.o, Ergomed d.o.o. Beograd, Ergomed Clinical Research Inc., MS Clinical Services, LLC and MedSource UK Ltd.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
September 29th, 2000
Public Since
July 15th, 2014
No. of Employees
1,255
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
49,519,629

ERGO Share Price Performance

Latest News for ERGO

Upcoming Events for ERGO

Half Year 2022 Ergomed PLC Earnings Release

Similar to ERGO

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of 4d Pharma logo

4d Pharma

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Picture of Arecor Therapeutics logo

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo

Avacta

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email